Gülşen Özen

960 citations
31 papers · 590 indexed · h-index 13
Topics
Rheumatoid Arthritis Research and Therapies (15 papers)Autoimmune and Inflammatory Disorders Research (6 papers)Vasculitis and related conditions (5 papers)

In The Last Decade

Gülşen Özen

30 papers receiving 583 citations

Peers

Gülşen Özen
Comparison fields: 5 of 69
  • Rheumatology 372
  • Immunology 98
  • Hematology 86
  • Pathology and Forensic Medicine 81
  • Molecular Biology 76
Replace Döndü Üsküdar Cansu with:
Döndü Üsküdar Cansu Türkiye
Deva Situnayake United Kingdom
René Cordtz Denmark
Levent Kılıç Türkiye
Maria-Victoria Egurbide Spain
Gunnstein Bakland Norway
Linlin Cheng China
Ciprian Jurcuț Romania
Monique Hoekstra Netherlands
Dongbao Zhao China
Gülşen Özen relative to Döndü Üsküdar Cansu Türkiye Döndü Üsküdar Cansu's profile →
Citations per field
00.5×1.7×
Döndü Üsküdar Cansu · 1×
Citations per year

Countries citing papers authored by Gülşen Özen

Since Specialization
Citations

This map shows the geographic impact of Gülşen Özen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülşen Özen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülşen Özen more than expected).

Fields of papers citing papers by Gülşen Özen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülşen Özen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülşen Özen. The network helps show where Gülşen Özen may publish in the future.

Co-authorship network of co-authors of Gülşen Özen

This figure shows the co-authorship network connecting the top 25 collaborators of Gülşen Özen. A scholar is included among the top collaborators of Gülşen Özen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülşen Özen. Gülşen Özen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 5
3 0
4 8
5 2
6 16
7 4
8 68
9 62
10 45
11 43
12 5
13 56
14 26
15 6
16 21
17 5
18 1
19 28
20 18

About Gülşen Özen

Gülşen Özen is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine, having authored 31 papers that have together received 590 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (15 papers), Autoimmune and Inflammatory Disorders Research (6 papers) and Vasculitis and related conditions (5 papers). The work is most often cited by research in Rheumatology (372 citations), Hematology (86 citations) and Genetics (65 citations). Gülşen Özen has collaborated with scholars based in Türkiye, United States and Canada. Frequent co-authors include Kaleb Michaud, Sofia Pedro, Frederick Wolfe, Haner Di̇reskeneli̇, Ted R. Mikuls, Bella Mehta, André C. Kalil, Nevsun İnanç, Pamir Atagündüz and Teresa A. Simon. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026